The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMW 2019 | Targeted therapy in MM
Sagar Lonial, MD, Emory University School of Medicine, Atlanta, GA, Enrique Ocio, Marquis de Valdecilla University Hospital, Santander, Spain, and Rafael Fonseca, MD, Mayo Clinic, Scottsdale, AZ, speaking at a roundtable meeting at the International Myeloma Workshop (IMW) 2019, held in Boston, MA. The speakers discuss targetted therapy including MCL1 and BCL2 and related clinical trials.
